U.S., Aug. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07771166) titled 'Effects of N-Acyl Taurines on Incretin Levels in Healthy Subjects' on Aug. 05.
Brief Summary: This study is an investigator-initiated, randomised, double-blind, placebo-controlled, cross-over human trial investigating the effect of arachidonoyl-taurine (C20:4-taurine) and oleoyl-taurine (C18:1-taurine) on GLP-1 secretion during fasting and feeding.
Study Start Date: June, 2027
Study Type: INTERVENTIONAL
Condition:
Cardiometabolic Conditions
Intervention:
OTHER: Placebo: First dose at 0 hours
Vehicle (ultrapure water with 10 % fish sauce), orally administered
OTHER: Arachidonoyl-taurine: First dose at 0 hours
Arachidonoyl-ta...